BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78 | -35.5% | 2,064 | -22.5% | 0.00% | -40.0% |
| Q2 2023 | $121 | -8.3% | 2,664 | -18.0% | 0.01% | -16.7% |
| Q1 2023 | $132 | -20.5% | 3,247 | -0.5% | 0.01% | -14.3% |
| Q4 2022 | $166 | -99.9% | 3,264 | -2.0% | 0.01% | -22.2% |
| Q3 2022 | $179,000 | -2.2% | 3,329 | +16.8% | 0.01% | 0.0% |
| Q2 2022 | $183,000 | -17.6% | 2,851 | -0.5% | 0.01% | -10.0% |
| Q1 2022 | $222,000 | -13.6% | 2,865 | -4.4% | 0.01% | -9.1% |
| Q4 2021 | $257,000 | -0.4% | 2,997 | -6.6% | 0.01% | -15.4% |
| Q3 2021 | $258,000 | -0.4% | 3,208 | -0.2% | 0.01% | 0.0% |
| Q2 2021 | $259,000 | -1.9% | 3,215 | +2.9% | 0.01% | -7.1% |
| Q1 2021 | $264,000 | -30.3% | 3,124 | -33.9% | 0.01% | -39.1% |
| Q4 2020 | $379,000 | -11.4% | 4,723 | -11.2% | 0.02% | -20.7% |
| Q3 2020 | $428,000 | -7.2% | 5,317 | -0.6% | 0.03% | -12.1% |
| Q2 2020 | $461,000 | +5.0% | 5,349 | -1.1% | 0.03% | -13.2% |
| Q1 2020 | $439,000 | -3.1% | 5,410 | -0.1% | 0.04% | +18.8% |
| Q4 2019 | $453,000 | -5.0% | 5,418 | -0.6% | 0.03% | -13.5% |
| Q3 2019 | $477,000 | +189.1% | 5,450 | +170.6% | 0.04% | +164.3% |
| Q2 2019 | $165,000 | -6.8% | 2,014 | -7.4% | 0.01% | -12.5% |
| Q1 2019 | $177,000 | +19.6% | 2,174 | -3.2% | 0.02% | +6.7% |
| Q4 2018 | $148,000 | -30.8% | 2,246 | -19.2% | 0.02% | -25.0% |
| Q3 2018 | $214,000 | +18.2% | 2,780 | +13.7% | 0.02% | +11.1% |
| Q2 2018 | $181,000 | +12.4% | 2,446 | -1.3% | 0.02% | +12.5% |
| Q1 2018 | $161,000 | -0.6% | 2,478 | -1.0% | 0.02% | -5.9% |
| Q4 2017 | $162,000 | +3.2% | 2,504 | +0.0% | 0.02% | -10.5% |
| Q3 2017 | $157,000 | +4.0% | 2,503 | +0.0% | 0.02% | -5.0% |
| Q2 2017 | $151,000 | +15.3% | 2,502 | -1.2% | 0.02% | +5.3% |
| Q1 2017 | $131,000 | +23.6% | 2,533 | +6.1% | 0.02% | +11.8% |
| Q4 2016 | $106,000 | -4.5% | 2,388 | +2.4% | 0.02% | -15.0% |
| Q3 2016 | $111,000 | +2.8% | 2,332 | -2.5% | 0.02% | -4.8% |
| Q2 2016 | $108,000 | -4.4% | 2,393 | -13.1% | 0.02% | -8.7% |
| Q1 2016 | $113,000 | -5.8% | 2,754 | -12.6% | 0.02% | -11.5% |
| Q4 2015 | $120,000 | -10.4% | 3,152 | -22.5% | 0.03% | -10.3% |
| Q3 2015 | $134,000 | -56.9% | 4,066 | -8.5% | 0.03% | -53.2% |
| Q2 2015 | $311,000 | +2.0% | 4,443 | -0.3% | 0.06% | -3.1% |
| Q1 2015 | $305,000 | -26.7% | 4,458 | -21.5% | 0.06% | -34.0% |
| Q4 2014 | $416,000 | -8.0% | 5,677 | -10.0% | 0.10% | -14.2% |
| Q3 2014 | $452,000 | -12.1% | 6,305 | -11.4% | 0.11% | -13.7% |
| Q2 2014 | $514,000 | +27.5% | 7,113 | +29.8% | 0.13% | +18.0% |
| Q1 2014 | $403,000 | +23.6% | 5,481 | +16.9% | 0.11% | +0.9% |
| Q4 2013 | $326,000 | +33.6% | 4,689 | +26.3% | 0.11% | +22.2% |
| Q3 2013 | $244,000 | -8.3% | 3,712 | -3.4% | 0.09% | -15.9% |
| Q2 2013 | $266,000 | – | 3,844 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |